CRISPR-based cancer therapies likely to be a disruptive technology in healthcare: GlobalData EP News Bureau Mar 13, 2021 Three leading companies racing to bring CRISPR therapies to the clinic are CRISPR Therapeutics, Intellia Therapeutics and Editas…
Novartis collaborates with Intellia Therapeutics and Caribou Biosciences Usha Sharma Jan 7, 2015 To explore making medicines and drug discovery tools with CRISPR genome editing technology
